Call for Abstracts

Important Dates:

  • Abstract Submission is now open.

  • Notification of Acceptance: July 25, 2021.

  • Abstract Submission Opens on March 10, 2021

  • Deadline Extended: Abstract Submission has been extended until July 1, 2021

General Information:

Authors are invited to submit abstracts for poster and oral submissions on original work for the MESOT 2021 Congress:

  • All abstracts must be submitted electronically through the MESOT 2021 Congress Website:  www.mesot2021-jo.com

  • There is no fee for submitting an abstract.

  • There is no limit to the number of abstracts you may submit.

  • Abstracts will be accepted in English only.

  • The corresponding author may indicate any preference for oral or poster presentation.

  • Submitted abstracts will be reviewed anonymously.

  • Presenting authors of accepted abstracts will be notified by July 25, 2021.

  • Presenting authors are required to register for the Congress.


Abstracts should concern all aspects of Transplantation, including the following themes:

  • Pre-Transplant Workup.

  • Donor Management

  • Expanded Criteria Donors

  • DSA Criteria for Desensitization.

  • Management of HCV in Solid Organ Transplantation.

  • Immunosuppression

    • Induction Therapy

    • Maintenance Immunosuppression

    • Future Immunosuppression and Unmet needs.

  • Liver Transplantation Experience.

  • Liver Transplantation Outcomes.

  • Liver Transplantation: HCC.

  • Kidney Transplantation.

  • Kidney Transplantation Surgery.

  • Kidney Transplantation Experience.

  • Advances in Kidney Transplantation.

  • Transplanting the Untransplantible

  • Kidney Paired Donation.

  • ABO Incompatible Transplantation.

  • HLA Incompatible Transplantation.

  • Heart and Lung Transplantation.

  • Transplanting the morbidly Obese: Surgical Issues.

  • Bone Marrow/Stem Cell Transplantation.

  • Cornea: Corneal Grafting, where are we?

  • Pancreas, Islet Cell and Intestinal Transplantation.

  • Pediatric Transplantation.

  • Transplantation in the COVID-19 Era.

  • Anti-COVID-19 Drugs and Immunosuppression Interaction.

  • Immunology.

    • HLA DR Typing and Incompatibility.

    • Immune Tolerance

    • Rejection

    • HLA Antibodies

  • Post-transplant Complications.

    • Recurrent Disease after Transplantation

    • Post-Transplant Infection

    • Post-Transplant Diabetes

    • Post-Transplant Hypertension

    • Post-Transplant Dyslipidemia

    • Post-Transplant Anemia

    • Post-Transplant BMD

    • Post-Transplant Obesity

    • Transplant Oncology

  • Graft Survival.

  • Facing the Failing Graft.

  • Organ Donation, Coordination and Organization.

  • Organ Procurement.

  • Brain Stem Death

  • Donation after brain death vs Cardiac death.

  • Ethics and Legislation


  • Declaration of Istanbul.

  • Abstracts should not exceed 300 words in length including Title, Authors and Affiliations.

  • Tables and graphics may be included and each will count as 80 words.

  • The text must be single spaced using an 11-point Arial font

  • You must use the following headings for a structured abstract layout:

    1. The title must be a concise short summary of your abstract.
      Capitalize all letters and do not use abbreviations.

    2. Capitalize and write the first letter of author’s first names then authors family names. Capitalize only the first letter of each family name. Underline the name of the presenting author.

    3. Indicate affiliations of co-authors: Department, institution, city and country.

    4. Leave one blank line before the main text.

    5. Body of the text describing Purpose, Materials and Methods, Results and Conclusions:
      Purpose of study: The issue being addressed, and if relevant, the hypothesis to be tested.
      Materials and Methods: Avoid abbreviations if possible; if you must use abbreviations, try to use explicit ones. Indicate statistical tests used at the end of this paragraph.
      Results and Discussion: Use SI units for all measurements. One figure or table can be used and must lie within the enclosed form boundaries. Make absolutely sure that figure or table symbols and text are large enough to allow reduction. Do not use three dimensional columns, dotted grid lines, or other unnecessary artwork in your figure or table.
      Conclusion(s): What you conclude from the results.

  • No references should be included.

Abstract Submission

  • Prepare your abstract according to the specifications above

  • Abstracts can be submitted online or by Email:

    • Online Submission,

    • Email Submission,


  • Receipt of abstracts will be acknowledged by email.
    If you do not receive a confirmation email with a receipt number that your abstract was successfully submitted, please contact the Congress Secretariat.

Kindly choose your preferred method of presentation:

Abstracts must be written exclusively in good English

Submitted Successfully !!